Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Publication
, Journal Article
Vikram, B
Published in: J Clin Oncol
February 15, 2001
Duke Scholars
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
February 15, 2001
Volume
19
Issue
4
Start / End Page
1233 / 1234
Location
United States
Related Subject Headings
- Xerostomia
- Randomized Controlled Trials as Topic
- Radiation-Protective Agents
- Oncology & Carcinogenesis
- Humans
- Head and Neck Neoplasms
- Amifostine
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vikram, B. (2001). Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol, 19(4), 1233–1234. https://doi.org/10.1200/JCO.2001.19.4.1233
Vikram, B. “Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.” J Clin Oncol 19, no. 4 (February 15, 2001): 1233–34. https://doi.org/10.1200/JCO.2001.19.4.1233.
Vikram B. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2001 Feb 15;19(4):1233–4.
Vikram, B. “Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.” J Clin Oncol, vol. 19, no. 4, Feb. 2001, pp. 1233–34. Pubmed, doi:10.1200/JCO.2001.19.4.1233.
Vikram B. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2001 Feb 15;19(4):1233–1234.
Published In
J Clin Oncol
DOI
ISSN
0732-183X
Publication Date
February 15, 2001
Volume
19
Issue
4
Start / End Page
1233 / 1234
Location
United States
Related Subject Headings
- Xerostomia
- Randomized Controlled Trials as Topic
- Radiation-Protective Agents
- Oncology & Carcinogenesis
- Humans
- Head and Neck Neoplasms
- Amifostine
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences